healthcare.digital December 2, 2025
The European HealthTech and MedTech M&A landscape in 2026 is poised for significant strategic acceleration, marking a transition from cautious, volume-driven dealmaking to high-value, transformative transactions. Deal flow is consolidating toward fewer but substantially larger deals, with market participants prioritising scalable technologies with robust clinical validation and AI integration capabilities.
Market Outlook and Deal Activity Forecast
Global M&A volumes are expected to surge, with Goldman Sachs projecting deal flow could reach $3.9 Trillion in 2026, potentially surpassing the 2021 record. European healthcare M&A demonstrated remarkable resilience in 2025, with an 87% spike in deal value reaching €31.8 Billion in the first half of 2025, despite an 8% decline in deal count. This “bigger cheques, fewer bets” approach signals a maturing...
Today's Sponsors
Today's Sponsor